Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)
NCT00541320 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2013-04-04
Summary
This study was designed to assess the safety and efficacy of GW813893 in the prophylaxis of VTE following TKR and to provide evidence to enable the selection of the appropriate dose(s) and dose regimen of GW813893 for future investigation.
Conditions
- Venous Thromboembolism
Interventions
- DRUG
-
GW813893
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials, MD · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-02-28
Countries
- United States
Study Locations
More Related Trials
-
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
NCT00917254 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement
NCT00152971 ·Status: COMPLETED ·Phase: PHASE3
-
Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery
NCT01153698 ·Status: TERMINATED
-
Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty
NCT02271399 ·Status: COMPLETED ·Phase: PHASE2
-
Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery
NCT00793234 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
NCT01203072 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty
NCT01809054 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
NCT03891524 ·Status: COMPLETED ·Phase: PHASE2
-
BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery
NCT01225822 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT06825416 ·Status: COMPLETED ·Phase: PHASE3
-
SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT05752461 ·Status: COMPLETED ·Phase: PHASE2
-
Selective Thromboembolism Prophylaxis After Arthroplasty
NCT03804697 ·Status: COMPLETED ·Phase: NA
-
FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT03276143 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery
NCT03251482 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery
NCT01431456 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty
NCT02379663 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-confirmatory Bridging Study in Total Knee Replacement
NCT01206972 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00371683 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery
NCT00913120 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prevention of Thromboembolic Events in Total Knee Replacement Patients
NCT03393481 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)
NCT01523418 ·Status: WITHDRAWN
-
Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement
NCT03812328 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement
NCT00362492 ·Status: COMPLETED ·Phase: PHASE4
-
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00452530 ·Status: COMPLETED ·Phase: PHASE3
-
Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty
NCT00657150 ·Status: COMPLETED ·Phase: PHASE3